ChemoMetec A/S (CPH:CHEMM)
Denmark · Delayed Price · Currency is DKK 377.60
+22.60 (6.37%)
Jun 4, 2026, 4:59 PM CET
ChemoMetec Stock Forecast
Stock Price Forecast
According to 4 analysts polled by S&P Global, ChemoMetec stock has a consensus rating of "Strong Buy" and an average price target of kr 546.25. The average 1-year stock price forecast is 44.66% higher than the current stock price, while the lowest is kr 450.00 (+19.17%) and the highest is kr 650.00 (+72.14%).
Price Target: kr 546.25 (+44.66%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for ChemoMetec stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 4 | 4 |
Financial Forecast
Revenue This Year
513.78M
from 495.57M
Increased by 3.67%
Revenue Next Year
567.73M
from 513.78M
Increased by 10.50%
EPS This Year
11.25
from 10.71
Increased by 5.02%
EPS Next Year
12.74
from 11.25
Increased by 13.23%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is DKK.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 516.0M | ||
| Avg | 513.8M | ||
| Low | 510.1M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 4.1% | ||
| Avg | 3.7% | ||
| Low | 2.9% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 11.99 | ||
| Avg | 11.25 | ||
| Low | 10.60 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 12.0% | ||
| Avg | 5.0% | ||
| Low | -1.0% |